Allergy 0 7 0 7 B-treatment
desensitization 8 23 8 23 I-treatment
injections 24 34 24 34 I-treatment

Any 0 3 35 38 O
investigational 4 19 39 54 B-treatment
therapeutic 20 31 55 66 I-treatment
medication 32 42 67 77 I-treatment

Concurrent 0 10 78 88 O
treatment 11 20 89 98 B-treatment
or 21 23 99 101 O
medications 24 35 102 113 B-treatment
( 36 37 114 115 O
must 37 41 115 119 O
be 42 44 120 122 O
off 45 48 123 126 O
for 49 52 127 130 O
at 53 55 131 133 O
least 56 61 134 139 O
1 62 63 140 141 B-lower_bound
week 64 68 142 146 I-lower_bound
) 68 69 146 147 O

Documented 0 10 148 158 O
negative 11 19 159 167 O
serum 20 25 168 173 O
βHCG 26 30 174 178 O
for 31 34 179 182 O
female 35 41 183 189 B-gender
patients 42 50 190 198 I-gender
who 51 54 199 202 O
are 55 58 203 206 O
post 59 63 207 211 O
- 63 64 211 212 O
menarchal 64 73 212 221 O

Eligible 0 8 222 230 O
histologies 9 20 231 242 O
include 21 28 243 250 O
glioblastoma 29 41 251 263 B-cancer
( 42 43 264 265 I-cancer
GBM 43 46 265 268 I-cancer
) 46 47 268 269 I-cancer
, 47 48 269 270 O
anaplastic 49 59 271 281 B-cancer
astrocytoma 60 71 282 293 I-cancer
( 72 73 294 295 I-cancer
AA 73 75 295 297 I-cancer
) 75 76 297 298 I-cancer
or 77 79 299 301 O
gliosarcoma 80 91 302 313 B-cancer

Growth 0 6 314 320 O
factors 7 14 321 328 O
( 15 16 329 330 O
e.g. 16 20 330 334 O
Procrit 21 28 335 342 B-treatment
® 28 29 342 343 I-treatment
, 29 30 343 344 O
Aranesp 31 38 345 352 B-treatment
® 38 39 352 353 I-treatment
, 39 40 353 354 O
Neulasta 41 49 355 363 B-treatment
® 49 50 363 364 I-treatment
) 50 51 364 365 O

HLA 0 3 366 369 B-chronic_disease
- 3 4 369 370 I-chronic_disease
A2 4 6 370 372 I-chronic_disease
positive 7 15 373 381 O
based 16 21 382 387 O
on 22 24 388 390 O
flow 25 29 391 395 B-treatment
cytometry 30 39 396 405 I-treatment

Interferon 0 10 406 416 B-treatment
( 11 12 417 418 O
e.g. 12 16 418 422 O
Intron 17 23 423 429 B-treatment
- 23 24 429 430 I-treatment
A 24 25 430 431 I-treatment
® 25 26 431 432 I-treatment
) 26 27 432 433 O

Interleukins 0 12 434 446 B-treatment
( 13 14 447 448 O
e.g. 14 18 448 452 O
Proleukin 19 28 453 462 B-treatment
® 28 29 462 463 O
) 29 30 463 464 O

Males 0 5 465 470 B-gender
and 6 9 471 474 I-gender
females 10 17 475 482 I-gender
must 18 22 483 487 O
agree 23 28 488 493 B-contraception_consent
to 29 31 494 496 I-contraception_consent
use 32 35 497 500 I-contraception_consent
effective 36 45 501 510 I-contraception_consent
birth 46 51 511 516 I-contraception_consent
control 52 59 517 524 I-contraception_consent
methods 60 67 525 532 I-contraception_consent
during 68 74 533 539 O
the 75 78 540 543 O
course 79 85 544 550 O
of 86 88 551 553 O
vaccination 89 100 554 565 B-contraception_consent

Newly 0 5 566 571 O
diagnosed 6 15 572 581 O
diffuse 16 23 582 589 B-treatment
intrinsic 24 33 590 599 I-treatment
pontine 34 41 600 607 I-treatment
gliomas 42 49 608 615 I-treatment
OR 50 52 616 618 O
any 53 56 619 622 O
biopsy 57 63 623 629 B-treatment
proven 64 70 630 636 O
high 71 75 637 641 O
- 75 76 641 642 O
grade 76 81 642 647 O
glioma 82 88 648 654 O
* 88 89 654 655 O
involving 90 99 656 665 O
the 100 103 666 669 O
brainstem 104 113 670 679 O
. 113 114 679 680 O
Patients 115 123 681 689 O
may 124 127 690 693 O
not 128 131 694 697 O
have 132 136 698 702 O
received 137 145 703 711 O
chemotherapy 146 158 712 724 B-treatment
during 159 165 725 731 O
or 166 168 732 734 O
after 169 174 735 740 O
radiation 175 184 741 750 B-treatment

Newly 0 5 751 756 O
diagnosed 6 15 757 766 O
high 16 20 767 771 O
- 20 21 771 772 O
grade 21 26 772 777 O
gliomas 27 34 778 785 B-cancer
with 35 39 786 790 O
metastatic 40 50 791 801 B-cancer
disease 51 58 802 809 I-cancer
within 59 65 810 816 O
the 66 69 817 820 O
CNS 70 73 821 824 O
requiring 74 83 825 834 O
craniospinal 84 96 835 847 B-treatment
radiation 97 106 848 857 I-treatment
therapy 107 114 858 865 I-treatment
. 114 115 865 866 O
Patients 116 124 867 875 O
may 125 128 876 879 O
or 129 131 880 882 O
may 132 135 883 886 O
not 136 139 887 890 O
have 140 144 891 895 O
received 145 153 896 904 O
chemotherapy 154 166 905 917 B-treatment
during 167 173 918 924 O
radiation 174 183 925 934 O
, 183 184 934 935 O
but 185 188 936 939 O
can 189 192 940 943 O
not 192 195 943 946 O
have 196 200 947 951 O
received 201 209 952 960 O
chemotherapy 210 222 961 973 O
after 223 228 974 979 O
radiation 229 238 980 989 O
therapy 239 246 990 997 O
was 247 250 998 1001 O
completed 251 260 1002 1011 O

Newly 0 5 1012 1017 O
diagnosed 6 15 1018 1027 O
high 16 20 1028 1032 B-cancer
- 20 21 1032 1033 I-cancer
grade 21 26 1033 1038 I-cancer
gliomas 27 34 1039 1046 I-cancer
* 34 35 1046 1047 O
or 36 38 1048 1050 O
brain 39 44 1051 1056 B-cancer
stem 45 49 1057 1061 I-cancer
gliomas 50 57 1062 1069 I-cancer
who 58 61 1070 1073 O
received 62 70 1074 1082 O
chemotherapy 71 83 1083 1095 B-treatment
during 84 90 1096 1102 O
radiation 91 100 1103 1112 B-treatment
therapy 101 108 1113 1120 I-treatment
. 108 109 1120 1121 O
Patients 110 118 1122 1130 O
may 119 122 1131 1134 O
not 123 126 1135 1138 O
have 127 131 1139 1143 O
received 132 140 1144 1152 O
chemotherapy 141 153 1153 1165 O
after 154 159 1166 1171 O
radiation 160 169 1172 1181 O
therapy 170 177 1182 1189 O
was 178 181 1190 1193 O
completed 182 191 1194 1203 O

Newly 0 5 1204 1209 O
diagnosed 6 15 1210 1219 O
, 15 16 1219 1220 O
non 17 20 1221 1224 O
- 20 21 1224 1225 O
brainstem 21 30 1225 1234 O
high 31 35 1235 1239 O
- 35 36 1239 1240 O
grade 36 41 1240 1245 O
glioma 42 48 1246 1252 B-chronic_disease
* 48 49 1252 1253 O
Patients 50 58 1254 1262 O
may 59 62 1263 1266 O
not 63 66 1267 1270 O
have 67 71 1271 1275 O
received 72 80 1276 1284 O
chemotherapy 81 93 1285 1297 B-treatment
during 94 100 1298 1304 O
or 101 103 1305 1307 O
after 104 109 1308 1313 O
radiation 110 119 1314 1323 B-treatment

No 0 2 1324 1326 O
overt 3 8 1327 1332 O
cardiac 9 16 1333 1340 B-chronic_disease
, 16 17 1340 1341 O
gastrointestinal 18 34 1342 1358 B-chronic_disease
, 34 35 1358 1359 O
pulmonary 36 45 1360 1369 B-chronic_disease
or 46 48 1370 1372 O
psychiatric 49 60 1373 1384 B-chronic_disease
disease 61 68 1385 1392 I-chronic_disease

Non 0 3 1393 1396 O
- 3 4 1396 1397 O
brainstem 4 13 1397 1406 O
high 14 18 1407 1411 B-cancer
- 18 19 1411 1412 I-cancer
grade 19 24 1412 1417 I-cancer
gliomas 25 32 1418 1425 I-cancer
* 32 33 1425 1426 O
that 34 38 1427 1431 O
have 39 43 1432 1436 O
recurred 44 52 1437 1445 O
following 53 62 1446 1455 O
treatment 63 72 1456 1465 B-treatment

Patients 0 8 1466 1474 O
enrolled 9 17 1475 1483 O
in 18 20 1484 1486 O
Strata 21 27 1487 1493 O
A 28 29 1494 1495 O
and 30 33 1496 1499 O
B 34 35 1500 1501 O
may 36 39 1502 1505 O
not 40 43 1506 1509 O
have 44 48 1510 1514 O
received 49 57 1515 1523 O
any 58 61 1524 1527 O
prior 62 67 1528 1533 B-treatment
chemotherapy 68 80 1534 1546 I-treatment
or 81 83 1547 1549 O
anti 84 88 1550 1554 B-treatment
- 88 89 1554 1555 I-treatment
glioma 89 95 1555 1561 I-treatment
therapy 96 103 1562 1569 I-treatment
of 104 106 1570 1572 O
any 107 110 1573 1576 O
type 111 115 1577 1581 O
other 116 121 1582 1587 O
than 122 126 1588 1592 O
radiation 127 136 1593 1602 B-treatment
therapy 137 144 1603 1610 I-treatment

Patients 0 8 1611 1619 O
enrolled 9 17 1620 1628 O
on 18 20 1629 1631 O
stratum 21 28 1632 1639 O
C 29 30 1640 1641 O
must 31 35 1642 1646 O
have 36 40 1647 1651 O
received 41 49 1652 1660 O
at 50 52 1661 1663 O
least 53 58 1664 1669 O
two 59 62 1670 1673 B-lower_bound
prior 63 68 1674 1679 B-treatment
chemotherapy 69 81 1680 1692 I-treatment
or 82 84 1693 1695 O
biologic 85 93 1696 1704 B-treatment
therapy 94 101 1705 1712 I-treatment
regimens 102 110 1713 1721 I-treatment
and 111 114 1722 1725 O
may 115 118 1726 1729 O
not 119 122 1730 1733 O
have 123 127 1734 1738 O
received 128 136 1739 1747 O
radiation 137 146 1748 1757 O
to 147 149 1758 1760 O
the 150 153 1761 1764 O
index 154 159 1765 1770 O
lesion 160 166 1771 1777 O
within 167 173 1778 1784 O
1 174 175 1785 1786 B-upper_bound
year 176 180 1787 1791 I-upper_bound
of 181 183 1792 1794 O
enrollment 184 194 1795 1805 O
. 194 195 1805 1806 O
Patients 196 204 1807 1815 O
on 205 207 1816 1818 O
Strata 208 214 1819 1825 B-clinical_variable
A 215 216 1826 1827 O
, 216 217 1827 1828 O
B 218 219 1829 1830 O
, 219 220 1830 1831 O
E 221 222 1832 1833 O
, 222 223 1833 1834 O
and 224 227 1835 1838 O
F 228 229 1839 1840 O
can 230 233 1841 1844 O
not 234 237 1845 1848 O
have 238 242 1849 1853 O
received 243 251 1854 1862 O
chemotherapy 252 264 1863 1875 O
after 265 270 1876 1881 O
radiation 271 280 1882 1891 B-treatment
therapy 281 288 1892 1899 I-treatment
was 289 292 1900 1903 O
completed 293 302 1904 1913 O

Patients 0 8 1914 1922 O
in 9 11 1923 1925 O
Stratum 12 19 1926 1933 O
A 20 21 1934 1935 O
B 22 23 1936 1937 O
and 24 27 1938 1941 O
E 28 29 1942 1943 O
must 30 34 1944 1948 O
have 35 39 1949 1953 O
received 40 48 1954 1962 O
standard 49 57 1963 1971 B-treatment
involved 58 66 1972 1980 I-treatment
field 67 72 1981 1986 I-treatment
radiation 73 82 1987 1996 I-treatment
therapy 83 90 1997 2004 I-treatment
[ 91 92 2005 2006 I-treatment
RT 92 94 2006 2008 I-treatment
] 94 95 2008 2009 I-treatment
defined 96 103 2010 2017 O
as 104 106 2018 2020 O
fractionated 107 119 2021 2033 B-treatment
external 120 128 2034 2042 I-treatment
beam 129 133 2043 2047 I-treatment
radiotherapy 134 146 2048 2060 I-treatment
with 147 151 2061 2065 O
total 152 157 2066 2071 B-clinical_variable
doses 158 163 2072 2077 I-clinical_variable
between 164 171 2078 2085 O
5000 172 176 2086 2090 B-lower_bound
- 176 177 2090 2091 O
6000 177 181 2091 2095 B-upper_bound
cGy 182 185 2096 2099 I-upper_bound
. 185 186 2099 2100 O
Patients 187 195 2101 2109 O
in 196 198 2110 2112 O
these 199 204 2113 2118 O
strata 205 211 2119 2125 O
must 212 216 2126 2130 O
be 217 219 2131 2133 O
registered 220 230 2134 2144 O
within 231 237 2145 2151 O
4 238 239 2152 2153 B-lower_bound
- 239 240 2153 2154 O
12 240 242 2154 2156 B-upper_bound
weeks 243 248 2157 2162 I-upper_bound
of 249 251 2163 2165 O
completing 252 262 2166 2176 O
RT 263 265 2177 2179 O

Patients 0 8 2180 2188 O
in 9 11 2189 2191 O
Stratum 12 19 2192 2199 O
F 20 21 2200 2201 O
must 22 26 2202 2206 O
have 27 31 2207 2211 O
received 32 40 2212 2220 O
craniospinal 41 53 2221 2233 B-treatment
radiation 54 63 2234 2243 I-treatment

Patients 0 8 2244 2252 O
in 9 11 2253 2255 O
Stratum 12 19 2256 2263 O
F 20 21 2264 2265 O
must 22 26 2266 2270 O
have 27 31 2271 2275 O
tumor 32 37 2276 2281 B-cancer
spread 38 44 2282 2288 O
within 45 51 2289 2295 O
the 52 55 2296 2299 O
CNS 56 59 2300 2303 O

Patients 0 8 2304 2312 O
must 9 13 2313 2317 O
be 14 16 2318 2320 O
clinically 17 27 2321 2331 O
stable 28 34 2332 2338 O
and 35 38 2339 2342 O
off 39 42 2343 2346 O
or 43 45 2347 2349 O
on 46 48 2350 2352 O
low 49 52 2353 2356 O
- 52 53 2356 2357 O
dose 53 57 2357 2361 O
( 58 59 2362 2363 O
no 59 61 2363 2365 O
more 62 66 2366 2370 O
than 67 71 2371 2375 O
0.1 72 75 2376 2379 B-lower_bound
mg 76 78 2380 2382 I-lower_bound
/ 78 79 2382 2383 I-lower_bound
kg 79 81 2383 2385 I-lower_bound
/ 81 82 2385 2386 I-lower_bound
day 82 85 2386 2389 I-lower_bound
, 85 86 2389 2390 O
max 87 90 2391 2394 O
4 91 92 2395 2396 B-upper_bound
mg 93 95 2397 2399 I-upper_bound
/ 95 96 2399 2400 I-upper_bound
day 96 99 2400 2403 I-upper_bound
Dexamethasone 100 113 2404 2417 B-treatment
) 113 114 2417 2418 O
corticosteroid 115 129 2419 2433 B-treatment
for 130 133 2434 2437 O
at 134 136 2438 2440 O
least 137 142 2441 2446 O
one 143 146 2447 2450 B-lower_bound
week 147 151 2451 2455 I-lower_bound
prior 152 157 2456 2461 I-lower_bound
to 158 160 2462 2464 O
study 161 166 2465 2470 O
registration 167 179 2471 2483 O

Patients 0 8 2484 2492 O
must 9 13 2493 2497 O
be 14 16 2498 2500 O
free 17 21 2501 2505 O
of 22 24 2506 2508 O
systemic 25 33 2509 2517 B-chronic_disease
infection 34 43 2518 2527 I-chronic_disease

Patients 0 8 2528 2536 O
must 9 13 2537 2541 O
be 14 16 2542 2544 O
≥ 17 18 2545 2546 O
12 19 21 2547 2549 B-lower_bound
months 22 28 2550 2556 I-lower_bound
and 29 32 2557 2560 O
< 33 34 2561 2562 O
22 34 36 2562 2564 B-upper_bound
years 37 42 2565 2570 I-upper_bound
of 43 45 2571 2573 O
age 46 49 2574 2577 B-age
at 50 52 2578 2580 O
the 53 56 2581 2584 O
time 57 61 2585 2589 O
of 62 64 2590 2592 O
study 65 70 2593 2598 O
registration 71 83 2599 2611 O

Patients 0 8 2612 2620 O
must 9 13 2621 2625 O
have 14 18 2626 2630 O
a 19 20 2631 2632 O
performance 21 32 2633 2644 B-clinical_variable
status 33 39 2645 2651 I-clinical_variable
of 40 42 2652 2654 O
≥ 43 44 2655 2656 O
to 45 47 2657 2659 O
60 48 50 2660 2662 B-lower_bound

Patients 0 8 2663 2671 O
must 9 13 2672 2676 O
have 14 18 2677 2681 O
life 19 23 2682 2686 B-clinical_variable
expectancy 24 34 2687 2697 I-clinical_variable
of 35 37 2698 2700 O
at 38 40 2701 2703 O
least 41 46 2704 2709 O
8 47 48 2710 2711 B-lower_bound
weeks 49 54 2712 2717 I-lower_bound

Patients 0 8 2718 2726 O
must 9 13 2727 2731 O
not 14 17 2732 2735 O
have 18 22 2736 2740 O
a 23 24 2741 2742 O
history 25 32 2743 2750 O
of 33 35 2751 2753 O
, 35 36 2753 2754 O
or 37 39 2755 2757 O
currently 40 49 2758 2767 O
active 50 56 2768 2774 O
autoimmune 57 67 2775 2785 B-chronic_disease
disorders 68 77 2786 2795 I-chronic_disease

Patients 0 8 2796 2804 O
on 9 11 2805 2807 O
Strata 12 18 2808 2814 O
C 19 20 2815 2816 O
and 21 24 2817 2820 O
D 25 26 2821 2822 O
must 27 31 2823 2827 O
have 32 36 2828 2832 O
recovered 37 46 2833 2842 O
from 47 51 2843 2847 O
the 52 55 2848 2851 O
toxic 56 61 2852 2857 O
effects 62 69 2858 2865 O
of 70 72 2866 2868 O
prior 73 78 2869 2874 B-treatment
therapy 79 86 2875 2882 I-treatment
: 86 87 2882 2883 O
at 88 90 2884 2886 O
least 91 96 2887 2892 O
3 97 98 2893 2894 B-lower_bound
weeks 99 104 2895 2900 I-lower_bound
form 105 109 2901 2905 O
the 110 113 2906 2909 O
last 114 118 2910 2914 O
dose 119 123 2915 2919 O
of 124 126 2920 2922 O
standard 127 135 2923 2931 B-treatment
cytotoxic 136 145 2932 2941 I-treatment
chemotherapy 146 158 2942 2954 I-treatment
or 159 161 2955 2957 O
myelosuppressive 162 178 2958 2974 B-treatment
biological 179 189 2975 2985 I-treatment
therapy 190 197 2986 2993 I-treatment
and 198 201 2994 2997 O
at 202 204 2998 3000 O
least 205 210 3001 3006 O
1 211 212 3007 3008 B-lower_bound
week 213 217 3009 3013 I-lower_bound
from 218 222 3014 3018 O
the 223 226 3019 3022 O
last 227 231 3023 3027 O
dose 232 236 3028 3032 O
of 237 239 3033 3035 O
non 240 243 3036 3039 B-treatment
- 243 244 3039 3040 I-treatment
myelosuppressive 244 260 3040 3056 I-treatment
biologic 261 269 3057 3065 I-treatment
therapy 270 277 3066 3073 I-treatment

Patients 0 8 3074 3082 O
with 9 13 3083 3087 O
adequate 14 22 3088 3096 O
organ 23 28 3097 3102 O
function 29 37 3103 3111 O
as 38 40 3112 3114 O
measured 41 49 3115 3123 O
by 50 52 3124 3126 O
: 52 53 3126 3127 O
Bone 54 58 3128 3132 O
marrow 59 65 3133 3139 O
: 65 66 3139 3140 O
ANC 67 70 3141 3144 B-clinical_variable
> 71 72 3145 3146 O
1,000/µl 73 81 3147 3155 B-lower_bound
; 81 82 3155 3156 O
Platelets 83 92 3157 3166 B-clinical_variable
> 93 94 3167 3168 O
100,000/µl 95 105 3169 3179 B-lower_bound
( 106 107 3180 3181 O
transfusion 107 118 3181 3192 B-treatment
independent 119 130 3193 3204 O
) 130 131 3204 3205 O
; 131 132 3205 3206 O
absolute 133 141 3207 3215 B-clinical_variable
lymphocyte 142 152 3216 3226 I-clinical_variable
count 153 158 3227 3232 I-clinical_variable
of 159 161 3233 3235 O
≥500 162 166 3236 3240 O
/ 166 167 3240 3241 I-lower_bound
uL 167 169 3241 3243 I-lower_bound
; 169 170 3243 3244 O
Hemoglobin 171 181 3245 3255 B-clinical_variable
> 182 183 3256 3257 O
8 183 184 3257 3258 B-lower_bound
g 185 186 3259 3260 I-lower_bound
/ 186 187 3260 3261 I-lower_bound
dl 187 189 3261 3263 I-lower_bound
( 190 191 3264 3265 O
may 191 194 3265 3268 O
be 195 197 3269 3271 O
transfused 198 208 3272 3282 O
) 208 209 3282 3283 O
. 209 210 3283 3284 O
Hepatic 211 218 3285 3292 O
: 218 219 3292 3293 O
bilirubin 220 229 3294 3303 B-clinical_variable
≤ 230 231 3304 3305 O
1.5x 232 236 3306 3310 B-upper_bound
institutional 237 250 3311 3324 I-upper_bound
normal 251 257 3325 3331 I-upper_bound
for 258 261 3332 3335 O
age 262 265 3336 3339 B-age
; 265 266 3339 3340 O
SGPT 267 271 3341 3345 B-clinical_variable
( 272 273 3346 3347 O
ALT 273 276 3347 3350 B-clinical_variable
) 276 277 3350 3351 O
< 278 279 3352 3353 O
3x 280 282 3354 3356 B-upper_bound
institutional 283 296 3357 3370 I-upper_bound
normal 297 303 3371 3377 I-upper_bound

Patients 0 8 3378 3386 O
with 9 13 3387 3391 O
any 14 17 3392 3395 O
oligodendroglioma 18 35 3396 3413 B-cancer
component 36 45 3414 3423 O

Patients 0 8 3424 3432 O
with 9 13 3433 3437 O
low 14 17 3438 3441 B-cancer
grade 18 23 3442 3447 I-cancer
gliomas 24 31 3448 3455 I-cancer
( 32 33 3456 3457 O
stratum 33 40 3457 3464 O
C 41 42 3465 3466 O
) 42 43 3466 3467 O
may 44 47 3468 3471 O
have 48 52 3472 3476 O
tumor 53 58 3477 3482 B-cancer
spread 59 65 3483 3489 O
within 66 72 3490 3496 O
the 73 76 3497 3500 O
CNS 77 80 3501 3504 O

Pregnant 0 8 3505 3513 B-pregnancy
females 9 16 3514 3521 B-gender

Presence 0 8 3522 3530 O
of 9 11 3531 3533 O
metastatic 12 22 3534 3544 B-cancer
disease 23 30 3545 3552 I-cancer
for 31 34 3553 3556 O
patients 35 43 3557 3565 O
in 44 46 3566 3568 O
Stratum 47 54 3569 3576 O
A 55 56 3577 3578 O
, 56 57 3578 3579 O
B 58 59 3580 3581 O
, 59 60 3581 3582 O
D 61 62 3583 3584 O
and 63 66 3585 3588 O
E 67 68 3589 3590 O

Renal 0 5 3591 3596 O
: 5 6 3596 3597 O
Serum 7 12 3598 3603 B-clinical_variable
creatinine 13 23 3604 3614 I-clinical_variable
based 24 29 3615 3620 O
on 30 32 3621 3623 O
age 33 36 3624 3627 B-age
or 37 39 3628 3630 O
Creatinine 40 50 3631 3641 B-clinical_variable
clearance 51 60 3642 3651 I-clinical_variable
or 61 63 3652 3654 O
radioisotope 64 76 3655 3667 B-clinical_variable
GFR 77 80 3668 3671 I-clinical_variable
> 81 82 3672 3673 O
70 82 84 3673 3675 B-lower_bound
ml 85 87 3676 3678 I-lower_bound
/ 87 88 3678 3679 I-lower_bound
min 88 91 3679 3682 I-lower_bound
/ 91 92 3682 3683 I-lower_bound
ml 92 94 3683 3685 I-lower_bound
/ 94 95 3685 3686 I-lower_bound
min/1.73 95 103 3686 3694 I-lower_bound
m² 104 106 3695 3697 I-lower_bound

Unresectable 0 12 3698 3710 O
low 13 16 3711 3714 O
- 16 17 3714 3715 O
grade 17 22 3715 3720 O
gliomas 23 30 3721 3728 B-cancer
that 31 35 3729 3733 O
have 36 40 3734 3738 O
received 41 49 3739 3747 O
at 50 52 3748 3750 O
least 53 58 3751 3756 O
two 59 62 3757 3760 B-lower_bound
chemotherapy 63 75 3761 3773 B-treatment
/ 75 76 3773 3774 O
biologic 76 84 3774 3782 B-treatment
regimens 85 93 3783 3791 I-treatment
. 93 94 3791 3792 O
Patients 95 103 3793 3801 O
may 104 107 3802 3805 O
not 108 111 3806 3809 O
have 112 116 3810 3814 O
received 117 125 3815 3823 O
radiation 126 135 3824 3833 B-treatment
to 136 138 3834 3836 O
the 139 142 3837 3840 O
index 143 148 3841 3846 O
lesion 149 155 3847 3853 O
within 156 162 3854 3860 O
1 163 164 3861 3862 B-upper_bound
year 165 169 3863 3867 I-upper_bound
of 170 172 3868 3870 O
enrollment 173 183 3871 3881 O

Use 0 3 3882 3885 O
of 4 6 3886 3888 O
immunosuppressives 7 25 3889 3907 B-treatment
within 26 32 3908 3914 O
four 33 37 3915 3919 B-upper_bound
weeks 38 43 3920 3925 I-upper_bound
prior 44 49 3926 3931 I-upper_bound
to 50 52 3932 3934 O
study 53 58 3935 3940 O
entry 59 64 3941 3946 O

